| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 171,442 | 130,058 | 105,921 | | Cost of Revenue | 136,111 | 99,489 | 84,425 | | | Gross Profit | 35,331 | 30,569 | 21,496 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 27,172 | 22,230 | 16,851 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 8,159 | 8,339 | 4,645 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 496 | 933 | 308 | | Earnings Before Interest And Taxes | 8,655 | 9,272 | 4,953 | | Interest Expense | 1,004 | 3,575 | 766 | | Income Before Tax | 7,651 | 5,697 | 4,187 | | Income Tax Expense | 2,687 | 2,042 | 1,205 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,964 | 3,655 | 2,982 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (247) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 4,964 | 3,655 | 2,735 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,964 | $3,655 | $2,735 |
|
0.34% Nasdaq 
Income Statement
